Literature DB >> 20082842

Epidermal growth factor receptor inhibitors: current status and future directions.

Helen X Chen1, Jessica N Cleck, Rochelle Coelho, Janet E Dancey.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20082842     DOI： 10.1016/j.currproblcancer.2009.10.002

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  5 in total

1.  Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.

Authors:  Craig D Woodworth; Laura P Diefendorf; David F Jette; Abdulmajid Mohammed; Michael A Moses; Sylvia A Searleman; Dan A Stevens; Katelynn M Wilton; Sumona Mondal
Journal:  Virology       Date:  2011-10-05       Impact factor: 3.616

2.  Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Authors:  Felix Amissah; Randolph Duverna; Byron J Aguilar; Rosemary A Poku; Gebre-Egziabher Kiros; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

3.  The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.

Authors:  Muhammad W Saif; Ewa Kontny; Kostas N Syrigos; Armin Shahrokni
Journal:  J Oncol       Date:  2011-06-13       Impact factor: 4.375

4.  Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma.

Authors:  Hong-Feng Gou; Xiang Li; Meng Qiu; Ke Cheng; Long-Hao Li; Hang Dong; Ye Chen; Yuan Tang; Feng Gao; Feng Zhao; Hai-Tao Men; Jun Ge; Jing-Mei Su; Feng Xu; Feng Bi; Jian-Jun Gao; Ji-Yan Liu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

5.  Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.

Authors:  Hidekazu Tanaka; Michinari Hirata; Satomi Shinonome; Toru Wada; Motofumi Iguchi; Keiji Dohi; Makiko Inoue; Yukichi Ishioka; Kanji Hojo; Tomomi Yamada; Tatsuya Sugimoto; Koichi Masuno; Ken-Ichi Nezasa; Norihito Sato; Kenji Matsuo; Shuji Yonezawa; Eugene P Frenkel; Michitaka Shichijo
Journal:  Cancer Sci       Date:  2014-08       Impact factor: 6.716
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.